Funding · Company
Asher Biotherapeutics, Inc.
South San Francisco, CABiotech & Pharma
Asher Biotherapeutics, Inc. of South San Francisco, CA has disclosed $163M across 2 Form D offerings filed with the SEC between Sep 7, 2021 and Apr 16, 2024.
$163M
Total disclosed
2
Form D offerings
2019
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
Filing details
HeadquartersSouth San Francisco, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2019SEC CIK0001787260Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →